HDAC inhibitor confers radiosensitivity to prostate stem-like cells
(2013)
Journal Article
Frame, F. M., Pellacani, D., Collins, A. T., Simms, M. S., Mann, V. M., Jones, G., …Maitland, N. J. (2013). HDAC inhibitor confers radiosensitivity to prostate stem-like cells. The British Journal of Cancer, 109(12), 3023-3033. https://doi.org/10.1038/bjc.2013.691
Background: Radiotherapy can be an effective treatment for prostate cancer, but radiorecurrent tumours do develop. Considering prostate cancer heterogeneity, we hypothesised that primitive stem-like cells may constitute the radiation-resistant fract... Read More about HDAC inhibitor confers radiosensitivity to prostate stem-like cells.